FR2371433A1 - Nouvelles imidazolidinethiones optiquement actives, procede pour les preparer et application a la preparation du tetramizole et du levamisole optiquement actifs - Google Patents

Nouvelles imidazolidinethiones optiquement actives, procede pour les preparer et application a la preparation du tetramizole et du levamisole optiquement actifs

Info

Publication number
FR2371433A1
FR2371433A1 FR7712566A FR7712566A FR2371433A1 FR 2371433 A1 FR2371433 A1 FR 2371433A1 FR 7712566 A FR7712566 A FR 7712566A FR 7712566 A FR7712566 A FR 7712566A FR 2371433 A1 FR2371433 A1 FR 2371433A1
Authority
FR
France
Prior art keywords
optically active
levamisole
imidazolidinethiones
tetramizole
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7712566A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/739,923 external-priority patent/US4087611A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FR2371433A1 publication Critical patent/FR2371433A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

L'invention concerne une nouvelle synthèse du tétramisole, du levamisole et de leurs dérivés. Plus particulièrement, l'invention concerne la synthèse de composés 1,3,4-trisubstitués de type imidazolidinone-2 ou imidazolidine-thione-2 de formule suivante :
FR7712566A 1976-04-26 1977-04-26 Nouvelles imidazolidinethiones optiquement actives, procede pour les preparer et application a la preparation du tetramizole et du levamisole optiquement actifs Pending FR2371433A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68030276A 1976-04-26 1976-04-26
US05/739,923 US4087611A (en) 1976-04-26 1976-11-08 Optically active 1-oxyethyl-4-phenyl-2-imidazolidones

Publications (1)

Publication Number Publication Date
FR2371433A1 true FR2371433A1 (fr) 1978-06-16

Family

ID=27102426

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7712566A Pending FR2371433A1 (fr) 1976-04-26 1977-04-26 Nouvelles imidazolidinethiones optiquement actives, procede pour les preparer et application a la preparation du tetramizole et du levamisole optiquement actifs

Country Status (16)

Country Link
JP (1) JPS52131579A (fr)
AR (1) AR214311A1 (fr)
AU (1) AU2341177A (fr)
DD (1) DD131170A5 (fr)
DE (1) DE2718058A1 (fr)
DK (1) DK181077A (fr)
ES (1) ES458163A1 (fr)
FR (1) FR2371433A1 (fr)
GB (1) GB1580352A (fr)
IL (1) IL51639A0 (fr)
IT (1) IT1086594B (fr)
NL (1) NL7704251A (fr)
NO (1) NO771421L (fr)
NZ (1) NZ183577A (fr)
SE (1) SE7704744L (fr)
SU (1) SU791231A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2370735A1 (fr) * 1976-04-26 1978-06-09 American Cyanamid Co Nouvelle synthese non asymetrique du tetramisole, du levamisole et derives correspondants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5010106A (fr) * 1973-05-24 1975-02-01
JPS5225301B2 (fr) * 1973-11-16 1977-07-06

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2370735A1 (fr) * 1976-04-26 1978-06-09 American Cyanamid Co Nouvelle synthese non asymetrique du tetramisole, du levamisole et derives correspondants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/78 *

Also Published As

Publication number Publication date
AR214311A1 (es) 1979-05-31
ES458163A1 (es) 1979-06-01
IL51639A0 (en) 1977-05-31
NZ183577A (en) 1980-03-05
NL7704251A (nl) 1977-10-28
DK181077A (da) 1977-10-27
JPS52131579A (en) 1977-11-04
IT1086594B (it) 1985-05-28
SE7704744L (sv) 1977-10-27
DE2718058A1 (de) 1977-11-17
NO771421L (no) 1977-10-27
AU2341177A (en) 1978-09-21
GB1580352A (en) 1980-12-03
SU791231A3 (ru) 1980-12-23
DD131170A5 (de) 1978-06-07

Similar Documents

Publication Publication Date Title
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
FR2442849A1 (fr)
FR2430938A1 (fr) Nouvelles oxybenzylidenes bornanones, leur procede de preparation, et compositions cosmetiques les contenant
OA06900A (fr) Perfectionnements relatifs à des dérivés de N-arylbenzamides.
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2380266A1 (fr) Molybdates d'amines heterocycliques, procede d'obtention et application
FR2383171A1 (fr) Derives de thiopropanoylaminoacides utiles comme hypotenseurs
FR2445319A1 (fr) Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
FR2434802A1 (fr) Oxime-carbamates et carbonates utiles pour la protection des cultures
FR2361897A1 (fr) Nouveaux derives de la cephalosporine, leurs intermediaires et procede pour les preparer
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2423480A1 (fr)
FR2400008A1 (fr) Agents anti-hypertensifs
FR2369260A1 (fr) 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation
FR2358890A1 (fr) Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2371433A1 (fr) Nouvelles imidazolidinethiones optiquement actives, procede pour les preparer et application a la preparation du tetramizole et du levamisole optiquement actifs
FR2375206A1 (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2421616A1 (fr) Nouveaux medicaments constitues de derives de l'acide o-aminobenzoique
FR2397387A1 (fr) 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
FR2426688A1 (fr) Nouvelles neplanocines antibiotiques
FR2359828A1 (fr) 1-alkyl inferieur-4,5-dihydro-5-phenyl-2-alcoxy inferieur carbonylamino-imidazoles et leurs derives phenyles substitues